In probably the third Chinese drug scandal in two months after Zhejiang Huahai’s tainted valsartan API and Changchun Changsheng Life Sciences’ fabricated vaccine production data exposé, Fosun Pharma has allegedly fabricated a large number of production and testing records. More:
read moreIt was a U.S. drugmaker that first alerted the FDA that the valsartan API it got from a Chinese ingredient maker contained a potentially dangerous impurity. And in the process of investigating, the FDA learned something it hadn’t known: that
read moreAfter marquee HIV drug approvals last year for Gilead and GlaxoSmithKline, Merck scored FDA nods on Thursday for a new non-nucleoside reverse transcriptase inhibitor called doravirine, both alone and in a combo with other HIV drugs. More: Chasing top HIV
read moreWith oncology head Sue Mahony retiring Friday, Eli Lilly has her replacement ready to step in. Anne White, currently VP of portfolio management for Lilly’s Chorus and next-generation R&D units, will take on the role of SVP and president of
read moreUS regulators have approved Bayer’s Jivi (formerly BAY94-9027), a longer-acting Factor VIII therapy designed to reduce the number of infusions necessary to prevent bleeds in patients with Haemophilia A. More: Bayer wins US nod for Jivi Source: News
read moreA novel treatment for patients with asthma uncontrolled by medicines that involves reducing muscle mass in the lungs has been approved for routine use on the NHS. More: Severe asthma patients to get ‘life-changing’ procedure on NHS Source: News
read more© 1994 - 2024 B.M. Pharmaceuticals